MLN3126

DRUG2 trials

Sponsors

Takeda

Conditions

Healthy VolunteersPharmacodynamicsPharmacokineticsSafetyTolerability

Phase 1

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MLN3126 in Healthy Japanese and Non-Japanese Participants

TerminatedNCT02209506

TakedaPharmacodynamics, Pharmacokinetics, Safety +1

Start: 2014-07-31End: 2014-12-31Updated: 2016-07-25

MLN3126 Single Rising Dose Study

TerminatedNCT02447458

TakedaHealthy Volunteers

Start: 2013-09-30End: 2014-02-28Updated: 2015-08-05